Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ]: Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ]: Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012
Tue, June 26, 2012
Mon, June 25, 2012
[ Mon, Jun 25th 2012 ]: Market Wire
Myths or Factsa" Campaign
Sun, June 24, 2012
Sat, June 23, 2012
Fri, June 22, 2012

August 2, 2012

  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/07/03/august-2-2012.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2012-07-03 13:29:12 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider

Haemonetics Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August... -- BRAINTREE, Mass., July 3, 2012 /PRNewswire/ --

Haemonetics Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August 2, 2012

[ ]
[ ]

BRAINTREE, Mass., July 3, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: [ HAE ]) will announce its earnings for the first quarter of its 2013 fiscal year on August 2, 2012 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on August 2, 2012.

(Logo:  [ http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ] )

Webcast Link: [ http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4802047 ]

Webcast replay will be available from August 2, 2012 after 11:00 am (EDT) until August 9, 2012.

Haemonetics (NYSE: [ HAE ]) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at [ http://www.haemonetics.com ].

CONTACT: Gerry Gould, VP-Investor Relations Tel. (781) 356-9402 [ gerry.gould@haemonetics.com ] Alt. (781) 356-9613  

 

 

 

SOURCE Haemonetics Corporation

[ Back to top ]

RELATED LINKS
[ http://www.haemonetics.com ]